Related Experiment Video
Updated: May 8, 2026

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model
Published on: October 14, 2016
Monoclonal rat anti-mouse brain antibody detects Abelson murine leukemia virus target cells in mouse bone marrow
Abstract:
We report the characterization of a monoclonal antibody which detects a surface antigen expressed by the bone marrow target cell of A-MuLV. Treatment of bone marrow cells with this antibody and complement results in greater than loss 95% loss of the A-MuLV-derived in vitro transformed foci. The surface antigen detected by this antibody is also expressed on A-MuLV-transformed lymphoid cell lines, thymocytes, and some peripheral lymphocytes. This antigen is not expressed, however, by the pluripotent hematopoietic stem cell defined by the spleen colony-forming assay. We present evidence that the antigen detected is neither a virally encoded product, nor exclusively associated with the BALB/c genome.
Insights
Researchers identified a novel surface antigen on bone marrow cells targeted by Abelson murine leukemia virus (A-MuLV). This discovery aids in understanding A-MuLV infection and developing targeted therapies.
Area of Science:
- Immunology
- Virology
- Hematology
Background:
- Abelson murine leukemia virus (A-MuLV) infects specific bone marrow cells.
- Targeting these cells is crucial for understanding viral pathogenesis and developing therapies.
Purpose of the Study:
- To characterize a monoclonal antibody recognizing a surface antigen on A-MuLV target cells.
- To determine the expression profile of this antigen on various hematopoietic cells.
Main Methods:
- Monoclonal antibody production and characterization.
- Complement-mediated cell lysis assays.
- Flow cytometry analysis of antigen expression.
Main Results:
- A monoclonal antibody was developed that detects a specific surface antigen on A-MuLV target bone marrow cells.
- Antibody treatment with complement eliminated >95% of A-MuLV-transformed foci in vitro.
- The antigen is present on A-MuLV-transformed lymphoid cells, thymocytes, and some peripheral lymphocytes, but not on pluripotent hematopoietic stem cells.
Conclusions:
- The identified antigen is a potential marker for A-MuLV target cells.
- This antigen is not a viral product and is not exclusive to the BALB/c genome.
- The antibody offers a tool for studying A-MuLV infection and potentially for therapeutic interventions.
More Related Videos
08:22Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production
Published on: May 31, 2020
08:31Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025